Repligen (RGEN) EBT (2010 - 2026)

Repligen (RGEN) has reported EBT for 17 consecutive years, with $14.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT fell 22.3% year-over-year to $14.2 million in Q2 2026; TTM through Jun 2026 was $75.7 million, a 199.7% increase from a year earlier, with the FY2025 full-year figure at $85.9 million, up 196.16% from the prior year.
• EBT was $14.2 million for Q2 2026 at Repligen, up from $1.8 million in the prior quarter.
• Over five years, EBT peaked at $59.8 million in Q2 2022 and troughed at -$100.9 million in Q4 2024.
• A 5-year average of $17.4 million and a median of $17.7 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT slumped 477.13% in 2024 and surged 1589.3% in 2025, its largest moves.
• Over 5 years, EBT stood at $53.0 million in 2022, then sank by 49.51% to $26.8 million in 2023, then tumbled by 477.13% to -$100.9 million in 2024, then jumped by 142.25% to $42.6 million in 2025, then plunged by 66.8% to $14.2 million in 2026.
• The last three EBT figures came in at $14.2 million (Q2 2026), $1.8 million (Q1 2026), and $42.6 million (Q4 2025), per Business Quant data.